Skip to main content
logo
TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
83.20
-1.80 (-2.12%)
At close: Dec 5, 2025

Revenue by Product

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Cancer Drugs
2.40B
Log In
Log In
Log In
Log In
Upgrade
Cancer Drugs Growth
-1.21%
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Drugs
1.22B
Log In
Log In
Log In
Log In
Upgrade
Anti-infective Drugs Growth
20.35%
Log In
Log In
Log In
Log In
Upgrade
Investment
1.12B
Log In
Log In
Log In
Log In
Upgrade
Investment Growth
37.00%
Log In
Log In
Log In
Log In
Upgrade
Export Sales and OEM
936.49M
Log In
Log In
Log In
Log In
Upgrade
Export Sales and OEM Growth
17.55%
Log In
Log In
Log In
Log In
Upgrade
Medical Insurance
186.34M
Log In
Log In
Log In
Log In
Upgrade
Medical Insurance Growth
-51.71%
Log In
Log In
Log In
Log In
Upgrade
Other
35.23M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-46.16%
Log In
Log In
Log In
Log In
Upgrade
Critical Care
-
Log In
Log In
Log In
Log In
Upgrade
Critical Care Growth
-
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular and Gastrointestinal Drugs
-
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular and Gastrointestinal Drugs Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Taiwan
5.12B
Log In
Log In
Log In
Log In
Upgrade
Taiwan Growth
5.78%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
391.78M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-1.73%
Log In
Log In
Log In
Log In
Upgrade
America
381.29M
Log In
Log In
Log In
Log In
Upgrade
America Growth
43.50%
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade